Alcon Inc. announced that it has commenced and priced a private offering of $700 million aggregate principal amount of its 5.375% senior notes due 2032 and $600 million aggregate principal amount of its 5.750% senior notes due 2052 (together, the “Notes”). The Notes will be issued by Alcon Finance Corporation, Alcon's indirect subsidiary, and will be fully and unconditionally guaranteed on a senior basis by Alcon. The offering is expected to close on December 6, 2022, subject to customary closing conditions.

Alcon intends to use the proceeds from the offering for general corporate purposes, including the repayment of all outstanding indebtedness under the bridge facility entered into in connection with its acquisition of Aerie Pharmaceuticals Inc., and to repay all or part of the outstanding indebtedness under its term loan facility.